Global Generic Pharmaceuticals Market
Pharmaceuticals

How Will the Generic Pharmaceuticals Market Grow? Key Trends and Opportunities for 2025 and Beyond

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the generic pharmaceuticals market grown in recent years?

The overall dimensions of the generic pharmaceuticals market have seen substantial expansion recently, with forecasts showing an increase from $457.04 billion in 2024 to $492.16 billion in 2025, equivalent to a compound annual growth rate (CAGR) of 7.7%. The surge during the historical period can be tied to enhanced healthcare awareness and spending, the termination of drug patents, a rise in lung-related conditions, lifestyle changes, an increase in surgical procedures, robust economic advancement in developing markets, growth in insurance coverage, a swift increase in the elderly population, and more product approvals.

How is the generic pharmaceuticals market size expected to evolve during the forecast period?

Expectations are high for the glamping market to experience a swift increase in size in the coming years, reaching a valuation of $5.49 billion in 2029 with a compound annual growth rate (CAGR) of 12.8%. This estimated growth over the forecast period can be credited to factors such as wellness and retreats, family-centric glamping, coordination with adventure tourism, corporate havens, and the overall increase in global tourism. The forecast period is also likely to see major trends emerging like the inclusion of technology and connectivity, more options that cater towards families for glamping, glamping-centric events and festivals, glamping sites that allow pets, along with partnerships with local craftsmen and designers.

Get your generic pharmaceuticals market report here!

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Which key drivers are propelling the generic pharmaceuticals market’s growth?

The upswing in chronic diseases serves as a significant catalyst for the growth of the generic pharmaceuticals market. With an increase in diagnoses of chronic illnesses, the demand for medication rises. Prescribed brand-name drugs often command a higher price, while generic medications, exhibiting identical chemical properties, are offered at a more affordable cost. This cost-effectiveness, coupled with an equivalent chemical formulation and potency, sways patients towards the acquisition of generic drugs rather than their branded counterparts. The prolonged duration of chronic disease treatments subsequently boosts the sales of these generic medications. The WHO (World Health Organization) forecasts that deaths due to chronic diseases are set to surge by 17% over the forthcoming decade. Hence, the escalating prevalence of such illnesses emerges as a significant instigator for the expansion of the generic pharmaceuticals market.

What are the market segments in the generic pharmaceuticals industry?

The generic pharmaceuticals market covered in this report is segmented –

1) By Type: Biosimilars, Generics

2) By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaled

3) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies

Subsegments:

1) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Other Biologic Products

2) By Generics: Branded Generics, Generic Small Molecules, Generic Extended-Release Formulations, Over-The-Counter (OTC) Generics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2479&type=smp

Which leading companies are shaping the growth of the generic pharmaceuticals market?

Major companies operating in the generic pharmaceuticals market include Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited, Cipla Limited, Stada Arzneimittel AG, Lupin Pharmaceuticals, Inc., Dr. Reddy’s Laboratories, Mylan Inc., Shanghai Generic Pharmaceuticals, Shanghai Acebright Generic Pharmaceuticals Group Co., Ltd., Sandoz, Glenmark, Kent Pharma, Zentiva, Apotex, Accord Healthcare Inc., Acerus Pharmaceutical Drugs Corporation, AA Pharma Inc, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, União Quimica, Boehringer Ingelheim, Mantecorp Farmasa, Libbs, Cimed, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Adcock Ingram, Eurolab, Ranbaxy (Pty) Ltd, Aspen

What key trends are currently impacting the generic pharmaceuticals market’s development?

The capability of 3D printing technology to revolutionize the production process within the generic pharmaceuticals market is undeniable. It aids in bolstering research and development productivity and provides novel advantages to patients. Unlike conventional manufacturing, 3D printing enables the production of drugs with individualized dimensions, shapes, and textures. Furthermore, it assists manufacturers in creating generic medicines with varied release schedules, appearances, and flavors. GlaxoSmithKline (GSK), for instance, leveraged ultraviolet (UV) and 3D printing techniques in a recent study to generate tablets for managing Parkinson’s disease. GSK’s Director of Technology, Martin Wallace, confirmed their investment in 3D printing for pill and tablet production. Another example includes the ‘ZipDose’ technology introduced by Aprecia pharmaceutical company, which entails the production of 3D printed pharmaceuticals.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2479

Which geographic areas are influencing the growth of the generic pharmaceuticals market?

North America was the largest region in the generic pharmaceuticals market in 2024. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Pharmaceutical Sterility Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Pharmaceutical Glass Packaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-glass-packaging-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: